Cargando…

Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health /

The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrict...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: National Research Council (U.S.). Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation
Otros Autores: Merrill, Stephen A., Mazza, Anne-Marie
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2006.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocm66295941
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 060411s2006 dcua ob 000 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCQ  |d NTE  |d IDEBK  |d OCLCQ  |d SNM  |d ORU  |d OCLCQ  |d TUU  |d OCLCQ  |d VAM  |d VAL  |d ADU  |d E7B  |d DKDLA  |d FVL  |d OCLCQ  |d ORU  |d OCLCQ  |d OCLCF  |d NLGGC  |d OCLCO  |d OCLCQ  |d EBLCP  |d DEBSZ  |d OCLCQ  |d AZK  |d VT2  |d OCLCQ  |d CASUM  |d OCLCO  |d TOA  |d OCLCO  |d MOR  |d PIFBR  |d ZCU  |d OCLCO  |d MERUC  |d OCLCQ  |d OCLCO  |d WY@  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d OCLCA  |d BUF  |d OCLCO  |d LUE  |d OCLCO  |d KIJ  |d STF  |d WRM  |d VTS  |d COCUF  |d AGLDB  |d NRAMU  |d EZ9  |d ICG  |d AU@  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCO  |d LVT  |d OCLCA  |d S9I  |d DKC  |d OCLCO  |d M8D  |d OCLCO  |d OCLCQ  |d OCLCA  |d UCW  |d OCLCA  |d UKAHL  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO 
016 7 |a 000040219600  |2 AU 
019 |a 65186074  |a 243609216  |a 473724995  |a 475337309  |a 614859884  |a 647482559  |a 722450063  |a 728040770  |a 923275191  |a 961641411  |a 962605417  |a 964921774  |a 971081720  |a 988508271  |a 991916200  |a 991949184  |a 1021250410  |a 1028809317  |a 1037913529  |a 1038647010  |a 1045559980  |a 1047578340  |a 1048145596  |a 1055344582  |a 1057972609  |a 1062888955  |a 1081180174  |a 1119428594  |a 1119434259  |a 1119457879  |a 1148124367  |a 1156343087  |a 1196350193  |a 1204380346  |a 1228548455  |a 1249221151 
020 |a 0309655234  |q (electronic bk.) 
020 |a 9780309655231  |q (electronic bk.) 
020 |a 9786610447220 
020 |a 6610447225 
020 |z 0309100674 
020 |z 9780309100670 
029 1 |a AU@  |b 000051519566 
029 1 |a DEBBG  |b BV043092608 
029 1 |a DEBBG  |b BV044108511 
029 1 |a DEBSZ  |b 42227772X 
029 1 |a DEBSZ  |b 452572339 
029 1 |a GBVCP  |b 801417082 
029 1 |a NZ1  |b 12037273 
035 |a (OCoLC)66295941  |z (OCoLC)65186074  |z (OCoLC)243609216  |z (OCoLC)473724995  |z (OCoLC)475337309  |z (OCoLC)614859884  |z (OCoLC)647482559  |z (OCoLC)722450063  |z (OCoLC)728040770  |z (OCoLC)923275191  |z (OCoLC)961641411  |z (OCoLC)962605417  |z (OCoLC)964921774  |z (OCoLC)971081720  |z (OCoLC)988508271  |z (OCoLC)991916200  |z (OCoLC)991949184  |z (OCoLC)1021250410  |z (OCoLC)1028809317  |z (OCoLC)1037913529  |z (OCoLC)1038647010  |z (OCoLC)1045559980  |z (OCoLC)1047578340  |z (OCoLC)1048145596  |z (OCoLC)1055344582  |z (OCoLC)1057972609  |z (OCoLC)1062888955  |z (OCoLC)1081180174  |z (OCoLC)1119428594  |z (OCoLC)1119434259  |z (OCoLC)1119457879  |z (OCoLC)1148124367  |z (OCoLC)1156343087  |z (OCoLC)1196350193  |z (OCoLC)1204380346  |z (OCoLC)1228548455  |z (OCoLC)1249221151 
043 |a n-us--- 
050 4 |a QH447  |b .R43 2006eb 
060 4 |a 2006 G-047 
060 4 |a QU 33 AA1  |b R288 2006 
072 7 |a SCI  |x 029000  |2 bisacsh 
082 0 4 |a 572.8/6  |2 22 
049 |a UAMI 
245 0 0 |a Reaping the benefits of genomic and proteomic research :  |b intellectual property rights, innovation, and public health /  |c Stephen A. Merrill and Anne-Marie Mazza, editors. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2006. 
300 |a 1 online resource (xvi, 171 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
500 |a "Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies." 
504 |a Includes bibliographical references. 
505 0 |a Genomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations. 
520 |a The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results. 
588 0 |a Print version record. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Genomics  |z United States  |x Patents. 
650 0 |a Proteomics  |z United States  |x Patents. 
650 0 |a Intellectual property  |z United States. 
650 0 |a Genomics. 
650 0 |a Proteomics. 
650 0 |a Intellectual property. 
650 0 |a Public health. 
650 2 |a Genomics 
650 2 |a Proteomics 
650 2 |a Intellectual Property 
650 2 |a Patents 
650 2 |a Public Health 
650 6 |a Génomique  |z États-Unis  |x Brevets d'invention. 
650 6 |a Protéomique  |z États-Unis  |x Brevets d'invention. 
650 6 |a Propriété intellectuelle  |z États-Unis. 
650 6 |a Génomique. 
650 6 |a Protéomique. 
650 6 |a Propriété intellectuelle. 
650 6 |a Santé publique. 
650 7 |a intellectual property.  |2 aat 
650 7 |a public health.  |2 aat 
650 7 |a SCIENCE  |x Life Sciences  |x Genetics & Genomics.  |2 bisacsh 
650 7 |a Public health  |2 fast 
650 7 |a Genomics  |2 fast 
650 7 |a Intellectual property  |2 fast 
650 7 |a Proteomics  |2 fast 
651 7 |a United States  |2 fast 
655 4 |a Fulltext. 
655 4 |a Internet Resources. 
655 4 |a Patents. 
655 7 |a patents.  |2 aat 
655 7 |a Patents  |2 fast 
655 7 |a Patents.  |2 lcgft 
655 7 |a Brevets d'invention.  |2 rvmgf 
700 1 |a Merrill, Stephen A. 
700 1 |a Mazza, Anne-Marie. 
710 2 |a National Research Council (U.S.).  |b Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation. 
776 0 8 |i Print version:  |t Reaping the benefits of genomic and proteomic research.  |d Washington, D.C. : National Academies Press, ©2006  |z 0309100674  |z 0309655234  |w (DLC) 2006921870  |w (OCoLC)66170484 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=156238  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36615470 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3378064 
938 |a ebrary  |b EBRY  |n ebr10120231 
938 |a EBSCOhost  |b EBSC  |n 156238 
938 |a YBP Library Services  |b YANK  |n 2416173 
994 |a 92  |b IZTAP